SEABELIFE

seabelife-logo

SeaBeLife is a biotechnology company that develops a range of drug candidates intended to block regulated necrosis (or regulated cell death of cells), from a family of patented molecules.

#SimilarOrganizations #People #Financial #Website #More

SEABELIFE

Social Links:

Industry:
Biotechnology Medical

Founded:
2019-01-01

Address:
Roscoff, Bretagne, France

Country:
France

Website Url:
http://www.seabelife.com

Total Employee:
1+

Status:
Active

Contact:
+33(0)2 98 29 23 48

Email Addresses:
contact@seabelife.com

Total Funding:
3.87 M EUR


Similar Organizations

nmd-pharma-logo

NMD Pharma

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

remix-therapeutics-logo

Remix Therapeutics

Remix Therapeutics is a biotechnology company.

theolytics-logo

Theolytics

Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.

vectivbio-logo

VectivBio

VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.

Current Employees Featured

morgane-rousselot_image

Morgane Rousselot
Morgane Rousselot Founder, President, and CEO @ SeaBeLife
Founder, President, and CEO

claire-delehouze_image

Claire Delehouze
Claire Delehouze CTO @ SeaBeLife
CTO

Founder


morgane-rousselot_image

Morgane Rousselot

Investors List

bpifrance_image

Bpifrance

Bpifrance investment in Grant - SeaBeLife

ava-capital_image

Ava capital

Ava capital investment in Seed Round - SeaBeLife

bpifrance_image

Bpifrance

Bpifrance investment in Seed Round - SeaBeLife

angels-sant_image

Angels Santé

Angels Santé investment in Seed Round - SeaBeLife

Official Site Inspections

http://www.seabelife.com

  • Host name: web1.anaximandre.com
  • IP address: 87.98.151.65
  • Location: France
  • Latitude: 48.8582
  • Longitude: 2.3387
  • Timezone: Europe/Paris

Loading ...

More informations about "SeaBeLife"

Seabelife – Sea inspired and life oriented biotech

SeaBeLife cible en priorité les pathologies aigües et orphelines (ou rares), avec un traitement unique ou court. Notre objectif est double : faciliter le développement clinique pour apporter …See details»

Seabelife – Sea inspired and life oriented biotech

SeaBeLife is a biotechnology company developing two families of patented candidate molecules designed to block regulated necrosis – also known as …See details»

SeaBeLife - Crunchbase Company Profile & Funding

Organization. SeaBeLife . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... SeaBeLife is a biotechnology company that …See details»

Management – Seabelife

SeaBeLife receives close to €1.4M deep tech financing from Bpifrance SeaBeLife Biotech raises € 1 million to carry onits drug developments targeting regulated cell death A biotech company …See details»

SeaBeLife - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... SeaBeLife . 1: obfuscated. …See details»

SeaBeLife Biotech - LinkedIn

SeaBeLife dans la presse / SeaBeLife cherche 8 millions d’euros d’ici début 2025 Un bel article paru dans BiotechFinances - Medtech - Santé Numérique - DTx - Intelligence Artificielle sur l ...See details»

Omnigen Biodata - Crunchbase Company Profile

Organization. Omnigen Biodata . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Alternatives and possible competitors to Omnigen Biodata may include SeaBeLife, Ascelia Pharma, and …See details»

SeaBeLife Biotech - healthtechinnovationdays6.com

SeaBeLife is pioneering a first-in-class approach to preventing organ failure by targeting dual inhibition of necroptosis and ferroptosis, pathways involved in severe liver and retinal …See details»

SeaBeLife receives Orphan Drug Designation (ODD) from EMA for …

Sep 3, 2024 SeaBeLife’s approach – based on dual action molecules that simultaneously target two different pathological cell death pathways – is unique in tackling the complex crosstalk …See details»

SeaBeLife Company Profile: Overview and Full News Analysis

SeaBeLife, a biotechnology company developing drug candidates to block cellular necrosis, today announces the award of more than 1.5M ($1.6M) in financing for its SeaBeEYE project at the i …See details»

SeaBeLife - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Nov 1, 2024 SeaBeLife is a biotechnology company that develops a range of drug candidates.See details»

SeaBeLife - EU-Startups

SeaBeLife’s technology centres around a portfolio of more than 45 biologically-active relevant molecules and the company has filed four patents to protect the applications of these …See details»

SeaBeLife Biotech - VentureRadar

SeaBeLife is a biotechnology company that is currently developing families of patented candidate molecules designed to block regulated necrosis (that is, regulated cell death). SeaBeLife …See details»

SeaBeLife receives close to €1.4M deep tech financing from …

Mar 14, 2022 Funds will enable SeaBeLife to develop pipeline of innovative molecules intended to block programmed cell death in cases of acute liver and kidney disease Roscoff, France, …See details»

SeaBeLife - Contacts, Employees, Board Members, Advisors

SeaBeLife is a biotechnology company that develops a range of drug candidates.See details»

News – Seabelife

Dec 8, 2023 SeaBeLife Biotech raises € 1.5 million to develop drugs targeting regulated cell death. Roscoff, June 15, 2020. SeaBeLife, a pharmaceutical … Lire la suite. Categories Press …See details»

Brittany-based biotech startup SeaBeLife picks up €1.4 million

Mar 14, 2022 Founded in 2019, SeaBeLife is a biotech startup developing drug candidates to block cell necrosis. Today, it’s announced a funding boost of almost €1.4 million financing from …See details»

SeaBeLife Biotech raises € 1 million to carry onits drug …

May 28, 2021 SeaBeLife, a pharmaceutical company focused on identifying a new class of drug candidates able to deprogram regulated cell death, announces its second seed money …See details»

SeaBeLife awarded over €1.5 million in i-Nov innovation competition

Apr 22, 2024 SeaBeLife currently employs eight people and since its creation has raised €5.5M ($5.86M) in private equity and grants. In 2023, the company raised €1.2M ($1.28M) in …See details»

News – Seabelife

Sep 3, 2024 SeaBeLife raises €1.2 M ($1.28 M) from iXLife fund and historical investors SeaBeLife receives close to €1.4M deep tech financing from Bpifrance A biotech company …See details»

linkstock.net © 2022. All rights reserved